Profile picture

Ms Emily Ghanbari

Berlin (Germany)
Follow
Logo ESC

Contributor content

Investigating the role of protease-activated receptor 2 in adverse cardiac remodeling and clinical outcomes in heart failure: insights from translational research
Presentation
Investigating the role of protease-activated receptor 2 in adverse cardiac remodeling and clinical outcomes in heart failure: insights from translational research
Genotype-dependent NT-proBNP, cardiac remodeling and pharmacokinetic marker dynamics after acute decompensation in heart failure: insights from the BeLove study
Presentation
Genotype-dependent NT-proBNP, cardiac remodeling and pharmacokinetic marker dynamics after acute decompensation in heart failure: insights from the BeLove study
Aortic regurgitation: links to declining hepatic-renal function, WWP-2 and IL-6 by genetic data
Presentation
Aortic regurgitation: links to declining hepatic-renal function, WWP-2 and IL-6 by genetic data
Protease-activated receptor 2 (PAR2) inhibition reduces complement-associated cardiac remodelling in obesity-related heart failure
Presentation
Protease-activated receptor 2 (PAR2) inhibition reduces complement-associated cardiac remodelling in obesity-related heart failure

ESC 365 is supported by